Becker's Oncology

Advertisement


Upcoming Events & Conferences

Most Read

Becker’s offerings

  • Events

    Where healthcare leaders meet — see what’s coming up.

  • Webinars

    Explore and register for webinars across a wide variety of topics.

  • Whitepapers

    Gain valuable insights & knowledge from our leading industry experts.

  • Podcasts

    Listen to interviews and conversations on healthcare’s most pressing issues.


The Latest

Patients with endometrial hyperplasia or benign uterine pathology had a 66% reduced risk of developing endometrial cancer when treated with progestins and a GLP-1 compared to patients treated with progestins alone, according to a study published Feb. 10 in JAMA…

In November, Peoria, Ill.-based OSF HealthCare named James McGee, MD, president of the system’s cancer institute. Dr. McGee grew up on a small farm in central Illinois, where limited access to care shaped his early understanding of rural healthcare gaps.…

We have entered a decisive era for U.S. cancer care. Seventy percent of people now live at least five years after a cancer diagnosis, an unprecedented milestone founded on decades of scientific research. Yet these gains are not shared equally…

In a move that underscores Duarte, Calif.-based City of Hope’s mission to translate scientific discovery into real-world outcomes, the organization recently appointed Vanessa Almendro Navarro, PhD, as chief commercialization officer.  In her role, Dr. Almendro Navarro is at the helm…

The Surgical Review Corporation has named Newport Beach, Calif.-based Hoag the world’s first center of excellence in oncoplastic breast surgery. In a Feb. 11 news release, Nirav Savalia, MD, medical director of oncoplastic and aesthetic breast surgery at Hoag, said…

In April, Bend, Ore.-based St. Charles Health System will open a cancer center in Redmond, Ore., that can serve up to 300 patients per day.  The facility will be nine times larger than the system’s current cancer care facilities in…

Orange, Calif.-based UCI Health has expanded the inpatient bed capacity of its stem-cell transplant program by 200% after opening the UCI Health — Irvine (Calif.) medical campus in December.  The inpatient suites are designed to facilitate customized cell therapy delivery…

Salt Lake City-based Huntsman Cancer Institute at the University of Utah will be the first U.S. academic medical center to manufacture a novel prostate cancer imaging drug, flotufolastat F 18. The drug was developed by Blue Earth Diagnostics and will…

Nisha Morris has been promoted to senior vice president and chief marketing and communications officer at Duarte, Calif.-based City of Hope. In the role, Ms. Morris will oversee enterprise and regional strategy for brand, marketing and external communications, the organization…

Advertisement

Advertisement
Advertisement
Advertisement
Advertisement